Israeli based OurCrowd Reveals 200 Million US$ Health Technology Fund
Date: 20, September 2022 Author: Market Statsville Group
On September 19, 2022, OurCrowd, an Israeli investment firm, revealed a $200 million technology-focused healthcare fund.
The online global venture investing platform OurCrowd established a million-dollar technology-focused healthcare fund named Global Health Equity Fund (GHEF). The company believes this fund would encourage innovation and raise financial support for the healthcare industry with the twin objectives of providing investors with competitive returns and ensuring that all people have access to quality healthcare.
According to OurCrowd, the fund was created due to the COVID-19 pandemic, which put pressure on health systems worldwide. It will concentrate on the medical field and sectors like food production and energy transition that affect health. The firm's portfolio would be focused on enhancing medical treatment and reducing dangers to the world's health brought on by the environment, fossil fuel use, and impending food shortages, it said.
About OurCrowd
Jonathan Medved, an angel investor and venture capitalist, started OurCrowd in February 2013 in Jerusalem. In 2012, Medved started to pursue the concept of an online platform that would democratize access to private equity investing. The company has offices in San Diego (U.S.), Tel Aviv, Herzliya, New York City, Toronto, London, Sydney, Madrid, Hong Kong, and Singapore. The company has established many funds since its founding, including a fund for the Australian innovation ecosystem, a Qure fund for digital health startups, and a portfolio index fund. OurCrowd also announced that their seed stage incubator labs invested in 100 early-stage startups over ten years.
Investment Trends in Health-Tech
At US$14 billion, venture funding for health tech inventors almost doubled from 2019 to 2020, and the trend was uninterrupted in 2021. It is anticipated that this momentum will continue in 2022 as digital health firms set the standard for healthcare innovation using telemedicine, artificial intelligence, machine learning, and data analytics. The post-pandemic period is seen by many investors, including CVCs, as the start of a multiyear opportunity rather than a bubble.
Most of the funding is expected to continue going to health tech entrepreneurs focused on creating goods and services that address well-being and care delivery, as well as open, secure data and interoperable platforms, in 2022 and beyond. Outside the United States, Israel and China are emerging as countries with interesting innovator and investor activities.
How Can Market Statsville Group (MSG) assist OurCrowd in Building Fortune?
OurCrowd's future investments and finances can be strategically planned with the support of thorough market research and expertise. OurCrowd can make an informed investment decision by thoroughly reviewing emerging technologies and adoption trends from market research and market entry strategic reports.
Get to know more about any particular market research study; kindly share your customer requirements with sales@marketstatsville.com